Philip Low Sample Contracts

SEC Documents
Filings
Personal financials
Insider transactions
Previous Companies
director, officer: Chief Science Officer until September 24th, 2013
Endocyte Inc – Patent Assignment Agreement (September 28th, 2010)

This Patent Assignment Agreement is entered into as of November 1, 2007 (the “Effective Date”), by and among Endocyte Inc., an Indiana corporation located at 3000 Kent Avenue, West Lafayette, IN 47906 (“Endocyte”); Optical Therapeutic Technologies Inc., an Indiana corporation located at 3000 Kent Avenue, West Lafayette, IN 47906 (“OTT”); and Karim N. Jallad, Michael D. Kennedy, Philip S. Low, and Dor Ben-Amotz, individuals residing at the addresses in the signature block (collectively, “Inventors”).